How severe is CVE-2023-25438?

CVE-2023-25438 has a CVSS 3.x base score of 7.8, rated high severity. It is exploitable over local access with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.

Is CVE-2023-25438 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 2% (79th percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2023-25438?

CVE-2023-25438 affects Genomedics Millegpg. See the affected-products list for the exact vulnerable versions.

How do I fix CVE-2023-25438?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.

When was CVE-2023-25438 published?

CVE-2023-25438 was published on 2023-05-04 and last updated on 2026-06-17.

CVE-2023-25438

CVE-2023-25438 is a high-severity vulnerability in Genomedics Millegpg with a CVSS 3.x base score of 7.8. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-732.

Key facts

Severity: High (CVSS 3.x base score 7.8)
EPSS exploit prediction: 2% (79th percentile)
Actively exploited: Not listed in CISA KEV
Weakness: CWE-732
Affected product: Genomedics Millegpg
Published: 2023-05-04
Last modified: 2026-06-17

Description

An issue was discovered in Genomedics MilleGP5 5.9.2, allows remote attackers to execute arbitrary code and gain escalated privileges via modifying specific files.

Frequently asked questions

What is CVE-2023-25438?: An issue was discovered in Genomedics MilleGP5 5.9.2, allows remote attackers to execute arbitrary code and gain escalated privileges via modifying specific files.
How severe is CVE-2023-25438?: CVE-2023-25438 has a CVSS 3.x base score of 7.8, rated high severity. It is exploitable over local access with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.
Is CVE-2023-25438 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 2% (79th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2023-25438?: CVE-2023-25438 affects Genomedics Millegpg. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2023-25438?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
When was CVE-2023-25438 published?: CVE-2023-25438 was published on 2023-05-04 and last updated on 2026-06-17.

References

Affected products (1)

cpe:2.3:a:genomedics:millegpg:5.9.2:*:*:*:*:*:*:*

Other CWE-732 (Incorrect Permission Assignment for Critical Resource) vulnerabilities

CVE-2026-9508 — Critical (CVSS 10.0): Incorrect permission settings on a critical resource in Suprema BioStar 2 (versions 2.9.3 through 2.9.11) that allow…
CVE-2025-14988 — Critical (CVSS 10.0): A security issue has been identified in ibaPDA that could allow unauthorized actions on the file system under certain…
CVE-2025-69426 — Critical (CVSS 10.0): The Ruckus vRIoT IoT Controller firmware versions prior to 3.0.0.0 (GA) contain hardcoded credentials for an operating…
CVE-2025-12004 — Critical (CVSS 10.0): Incorrect Permission Assignment for Critical Resource vulnerability in The Wikimedia Foundation Mediawiki - Lockdown…
CVE-2014-125121 — Critical (CVSS 10.0): Array Networks vAPV (version 8.3.2.17) and vxAG (version 9.2.0.34) appliances are affected by a privilege escalation…
CVE-2025-46093 — Critical (CVSS 9.9): LiquidFiles before 4.1.2 supports FTP SITE CHMOD for mode 6777 (setuid and setgid), which allows FTPDrop users to…

Browse all CWE-732 (Incorrect Permission Assignment for Critical Resource) vulnerabilities →